In the latest quarter, 4 analysts provided ratings for Oscar Health (NYSE:OSCR), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 0 | 2 | 1 |
Last 30D | 0 | 0 | 0 | 0 | 1 |
1M Ago | 0 | 0 | 0 | 2 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.0, a high estimate of $18.00, and a low estimate of $10.00. This current average represents a 25.01% decrease from the previous average price target of $18.67.
The standing of Oscar Health among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Jonathan Yong | UBS | Lowers | Sell | $11.00 | $15.00 |
Stephen Baxter | Wells Fargo | Lowers | Underweight | $10.00 | $16.00 |
Andrew Mok | Barclays | Announces | Underweight | $17.00 | - |
Jessica Tassan | Piper Sandler | Lowers | Overweight | $18.00 | $25.00 |
To gain a panoramic view of Oscar Health's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Oscar Health analyst ratings.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Oscar Health's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 42.16%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Oscar Health's net margin excels beyond industry benchmarks, reaching 9.22%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Oscar Health's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 23.93%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Oscar Health's ROA excels beyond industry benchmarks, reaching 5.26%. This signifies efficient management of assets and strong financial health.
Debt Management: Oscar Health's debt-to-equity ratio is below the industry average. With a ratio of 0.22, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.